Sign in
4

Changes in Ownership

RHYTHM PHARMACEUTICALS, INC. Filed Acc 0001104659-23-119091

Chief Financial Officer sold 12,000 shares at $30.38 ($364,573)

  • Chief Financial Officer acquired 12,000 shares (option exercise)

From the SEC's structured data for this filing

Trades in this filing

Table I: Non-derivative

Insider Date Transaction Shares Price Value Owned after D/I
Smith Hunter C Chief Financial Officer 2023-11-14 Option exercise +12,000 $6.88 $82,560 73,406 D: show line 1 in the form
Smith Hunter C Chief Financial Officer 2023-11-14 Sale −12,000 $30.38 $364,573 61,406 D: show line 2 in the form
Open-market sales · 12,000 sh · avg $30.38 · $364,573

Table II: Derivative

Insider Date Transaction Shares Price Value Owned after D/I
Smith Hunter C Chief Financial Officer 2023-11-14 Option exercise · Stock Option (Right to Buy) −12,000 149,094 D: show line 3 in the form
Loading xslF345X05/tm2330902-1_4seq1.xml…